batrafen
sanofi-aventis new zealand limited - ciclopirox 8% - nail lacquer - 8 % - active: ciclopirox 8% excipient: butyl ester of pvm/ma copolymer ethyl acetate isopropyl alcohol nitrogen
batrafen
sanofi-aventis new zealand limited - ciclopirox olamine 1%{relative} - topical cream - 1% w/w - active: ciclopirox olamine 1%{relative}
batrafen
sanofi-aventis new zealand limited - ciclopirox olamine 1%{relative} - topical solution - 1% w/v - active: ciclopirox olamine 1%{relative}
tavanic 500 mg solution for i.v. infusion
sanofi - aventis israel ltd - levofloxacin as hemihydrate - solution for infusion - levofloxacin as hemihydrate 5 mg/ml - levofloxacin - levofloxacin - in adults for whom intravenous therapy is considered to be appropriate, tavanic solution for infusion is indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: community- acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.
lantus xr 300 units (equivalent to 10.91 mg)/ml solution for injection (sc)
sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - insulin glargine - solution for injection (sc) - 300 units (equivalent to 10.91 mg)/ml
apidra 3.49 mg/ml (equivalent to 100 units/ml)
sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - insulin glulisine - solution for subcutaneous/continuous sc pump infusion/ intravenous injection - 3.49 mg/ml (equivalent to 100 units/ml)
apidra solostar 3.49 mg/ml (equivalent to 100 units/ml) solution for injection (sc)
sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - insulin glulisine - solution for injection (sc) - 3.49 mg/ml (equivalent to 100 units/ml)
sanofi caplets tablet blister pack
sanofi-aventis australia pty ltd - codeine phosphate hemihydrate,doxylamine succinate,paracetamol -
maalox plus 200mg/ 200mg/ 25mg chewable tablet
sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - aluminum hydroxide , magnesium hydroxide , simethicone - chewable tablet - 200mg/ 200mg/ 25mg
soliqua solution for injection (sc)
sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - insulin glargine/ lixisenatide - solution for injection (sc) - 3.64 mg (equivalent to 100 units of insulin glargine) 750 mcg per ml